R. Don Elsey, CFO at Emergent BioSolutions Inc. (EBS), sold 5,700 shares at $19.22 ($110K) on 2009-03-10, disclosed to the SEC on 2009-03-12.
Scheduled sale ($110k) by CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.00 | 47 | $893 | 0.8% |
| 2 | $19.03 | 53 | $1K | 0.9% |
| 3 | $19.05 | 100 | $2K | 1.7% |
| 4 | $19.06 | 100 | $2K | 1.7% |
| 5 | $19.10 | 200 | $4K | 3.5% |
| 6 | $19.15 | 200 |
| $4K |
| 3.5% |
| 7 | $19.16 | 200 | $4K | 3.5% |
| 8 | $19.17 | 100 | $2K | 1.7% |
| 9 | $19.18 | 100 | $2K | 1.7% |
| 10 | $19.20 | 400 | $8K | 7.0% |
| 11 | $19.21 | 200 | $4K | 3.5% |
| 12 | $19.22 | 100 | $2K | 1.8% |
| 13 | $19.24 | 200 | $4K | 3.5% |
| 14 | $19.25 | 400 | $8K | 7.0% |
| 15 | $19.25 | 300 | $6K | 5.3% |
| 16 | $19.28 | 200 | $4K | 3.5% |
| 17 | $19.29 | 200 | $4K | 3.5% |
| 18 | $19.30 | 100 | $2K | 1.8% |
| 19 | $19.30 | 1,000 | $19K | 17.6% |
| 20 | $19.31 | 100 | $2K | 1.8% |
| 21 | $19.32 | 200 | $4K | 3.5% |
| 22 | $19.33 | 200 | $4K | 3.5% |
| 23 | $19.35 | 400 | $8K | 7.0% |
| 24 | $19.38 | 100 | $2K | 1.8% |
| 25 | $19.43 | 100 | $2K | 1.8% |
| 26 | $19.46 | 100 | $2K | 1.8% |
| 27 | $19.47 | 100 | $2K | 1.8% |
| 28 | $19.49 | 200 | $4K | 3.5% |
| Total | $19.27 avg | 5,700 | $110K | 100% |
| Filing → |
| EBS | SELL | 2009-03-12 | $16K | — | Filing → |
| EBS | SELL | 2008-12-16 | $221K | — | Filing → |
| EBS | SELL | 2008-12-01 | $307K | — | Filing → |